Searching...Lobbying Arrangements: Pharmacy
New Lobbying Registrations About Pharmacy By Quarter
Former Covered Federal Workers:
Other Lobbyists:
| Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
|---|---|---|---|---|---|
| Details Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs. Pandemic Preparedness. H.R. 5376 - Build Back Better Act. Monitoring legislative and regulatory eff... |
Amneal
|
Mehlman Castagnetti Rosen & Thomas, Inc. | |||
| Details CJ reform |
Konstantin Bas
|
Frinzi & Associates | |||
| Details Outreach to Congress and Administration officials on FDA issues related to compound pharmacies and related matters. |
Ocular Science/OSRX
|
FTI Government Affairs | |||
| Details Promoting non-opioid pain management alternatives. |
Sorrento Therapeutics, Inc.
|
STONINGTON GLOBAL | |||
| Details Provide legislative and regulatory advice related to vaccine development, drug pricing, the 340B Drug Pricing Program, PDUFA Reauthorization, and clinical trial diversity; H.R.6000, Cures 2.0 Act; ... |
AstraZeneca Pharmaceuticals LP
|
Rampy Northrup LLC | |||
| Details any bill(s) or provision(s) related to the 340B Drug Discount Program. any provision(s) related to the Pandemic & All Hazards Preparedness Act (PAHPA) Reauthorization. any bill(s) or provision(s) ... |
Atrium Health - Formerly known as Carolinas HealthCare System
|
Atrium Health-Formerly known as Carolinas HealthCare System | |||
| Details HRSA 340B Program |
Avita Pharmacy
|
BALLARD PARTNERS | |||
| Details Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States. |
Centrient Pharmaceuticals LLC
|
AKIN GUMP STRAUSS HAUER & FELD | |||
| Details Re-shoring production of essential medicine |
1776 Pharmaceuticals LLC
|
COVINGTON & BURLING LLP | |||
| Details Domestic Manufacturing Medicare implications on biosimilars, Part D reform Drug Rebate Reform Appropriations pertaining to American Made preference HHS Supply Chain Readiness HHS Biosimilar Uptake ... |
Coherus Biosciences, Inc.
|
in-house lobbying | |||
| Details Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States. |
Centrient Pharmaceuticals LLC
|
AKIN GUMP STRAUSS HAUER & FELD | |||
| Details Pharmaceutical supply chain and API procurement, Global drug shortages, Tax reform Rebate reform, any willing pharmacy, PBMs, IRA Medicare Direct Negotiation, DIR fees IRA, Part D redesign, rebates... |
Fresenius Kabi USA LLC
|
in-house lobbying | |||
| Details COVID-19 vaccine development - manufacturing scale-up assistance |
Gritstone Oncology
|
THE KPM GROUP DC LLC | |||
| Details S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 S. 4071, the Helping Experts Accelerate Rare Treatments (HEART) Act H.R. 1184, the Helping Experts Accelerate Rare T... |
Aeglea BioTherapeutics, Inc.
|
THE KPM GROUP DC LLC | |||
| Details COVID -19 Stimulus Package (domestic manufacturing) |
Summit Therapeutics plc
Biopharmaceutical company; develops medicines to treat infectious diseases |
THE KPM GROUP DC LLC | |||
| Details Issues related to advanced pharmaceutical and domestic supply chain. |
Lyndra Therapeutics, Inc.
|
AMERICAN CONTINENTAL GROUP | |||
| Details Issues related to COVID-19 |
Alvogen, Pharma US, Inc.
|
Hogan Lovells US LLP | |||
| Details Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues. Administration of the 21st Century Cares Act (Pub. L. No. 1... |
Summit Public Affairs (for Vanda Pharmaceuticals, Inc.)
|
BRIDGEWAY ADVOCACY | |||
| Details Approval by FDA of Covid test Kit |
One Milo, Inc
Covid Test Kets and Personal Protective Equipment (PPE's) |
GOVERNMENT RELATIONS GROUP, LLC | |||
| Details Medical testing |
Visby Medical Inc.
|
Venable LLP | |||
| Details Food and Drug Administration, COVID-19 Testing |
Pure Blue Diagnostics, a division of Pure Blue Medical
|
RUBICON ADVISORS, LLC | |||
| Details Food and Drug Administration, Orphan Drugs |
Ascendis Pharma, Inc.
|
RUBICON ADVISORS, LLC | |||
| Details Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. Work with Department of Defense on Ebola counter... |
AIM ImmunoTech Inc.
|
Buchanan Ingersoll & Rooney, PC | |||
| Details Issues related to containment and delivery systems for injectable medicine. |
West Pharmaceutical Services, Inc.
|
Bryan Cave Leighton Paisner LLP | |||
| Details Issues related to COVID-19 Paycheck Protection Program; Provider Relief Fund |
University Radiology Group, P.C.
|
ANWAY LONG GROUP | |||
| Details Issues related to drug supply chains; generic drug shortage. |
AmerisourceBergen Corporation
|
ANWAY LONG GROUP | |||
| Details Mr. Keller lobbied Congress generally on issues related to pharmaceutical regulation and financial technology policies Mr. Keller lobbied generally on pharmaceutical and financial techology policy |
Aytu BioPharma, Inc. (formerly known as Aytu BioScience, Inc.)
|
DORSEY & WHITNEY LLP | |||
| Details Remote clinical trials, biomedical research & development, issues related to diversity in clinical trials, real world evidence, pandemic preparedness reauthorization. Clinical trials and research. ... |
Syneos Health, Inc.
|
Williams and Jensen, PLLC | |||
| Details Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. Farm Bill. National Animal Disease Preparedness and Response Program, and the... |
Boehringer Ingelheim USA Corporation
|
HANCE SCARBOROUGH | |||
| Details S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act H.R. 2617 - Consolidated Appropriations Act of 2023 - Medicare provisions to eliminate cuts in physician payment and Medicaid provisio... |
American Society of Hematology
|
ARTEMIS POLICY GROUP LLC |